Resource Center

Resource Center

CHAI invites interested and capable vendors to submit requests for proposals RFPs) for the supply of medical liquid oxygen and cryogenic vessels in the Democratic Republic of Congo
Read more
Invitation to bid for the procurement of pipeline and manifold materials, installation, and related services in Ethiopia
Read more
CHAI requests proposals for the supply and delivery of medical liquid oxygen (LOX) to designated public health facilities in Zambia
Read more
The Africa CDC, CHAI, and PATH have released a briefing paper, “Current and planned vaccine manufacturing in Africa,” following an assessment of vaccine manufacturing capacity in Africa
Read more
This study of Africa’s current and planned vaccine manufacturing capacity offers insights into how to target investments and development efforts to promote long-term success.
Read more
Results from a joint assessment by Africa CDC, CHAI, and PATH of current and planned vaccine manufacturing in Africa.
Read more
The Missing Billion Initiative, the McKinsey Health Institute, the Clinton Health Access Initiative, the International Disability Alliance, and the London School of Hygiene & Tropical Medicine have partnered to accelerate disability inclusion in health systems globally.
Read more
CHAI invitation to bid for the procurement of VIE tanks, vaporizers, installation, commissioning and associated civil works in two health facilities in Mozambique
Read more
*UPDATE – FAQs* We have received several questions regarding the ITBs (ITB/CHAI/VIE/TZM2301, ITB/CHAI/VIE/TZZ2301, ITB/CHAI/PIP/TZM2302 and ITB/CHAI/PIP/TZZ2302). Download this FAQ document for answers to these questions. Invitation to Bid (ITB) for the supply of VIE systems, civils, installation and commissioning services for various health facilities in Tanzania (Dar-Es-Salaam) The Clinton Health Access Initiative (CHAI) is a...
Read more
The Global Antibiotic Research & Development Partnership (GARDP) and India-based Orchid Pharma Ltd (Orchid) have signed a sublicense agreement to manufacture cefiderocol, an antibiotic to treat certain Gram-negative infections.
Read more